Ceres Group to Present at the UBS Global Healthcare Services Conference
February 08 2006 - 4:46PM
Business Wire
Ceres Group, Inc. (NASDAQ:CERG) today announced that its president
and chief executive officer, Tom Kilian, will present at the UBS
Global Healthcare Services Conference on Tuesday, February 14, at
2:30 p.m. ET in New York City at the Grand Hyatt New York.
Investors will be able to access the audio webcast via the UBS
Investment Bank website at www.ibb.ubs.com .The direct link to the
registration page is http://event.streamx.us/event/20060213 .
Following the live webcast, a replay of the presentation will be
available until March 15, 2006. Mr. Kilian's presentation including
slides will also be available on the Ceres website at
www.ceresgp.com. About Ceres Group Ceres Group, Inc., through its
insurance subsidiaries, provides a wide array of health and life
insurance products through two primary business segments. Ceres'
Medical Segment includes major medical health insurance for
individuals, families, associations and small businesses. The
Senior Segment includes senior health, life and annuity products
for Americans age 55 and over. To help control medical costs, Ceres
also provides medical cost management services to its insureds.
Ceres' nationwide distribution channels include independent and
career agents, as well as electronic distribution systems. Ceres is
included in the Russell 3000(R) Index. For more information, visit
www.ceresgp.com. This news release contains certain forward-looking
statements with respect to the financial condition, results of
operations and business of the company. Forward-looking statements
are statements other than historical information or statements of
current condition. In light of the risks and uncertainties inherent
in all future projections, the inclusion of forward-looking
statements herein should not be regarded as representation by the
company or any other person that the objectives or plans of the
company will be achieved. Many factors could cause actual results
to differ materially from those contemplated by such
forward-looking statements, including, among others, failure to
accurately predict loss ratios and improvements in our business,
business conditions and competition in the healthcare industry, the
failure to successfully implement the business plans (including the
company's growth strategy) for the company and its subsidiaries,
failure to accurately predict claims liabilities, ability to
institute necessary rate increases, ability to develop, market and
administer new and competitive products, developments in healthcare
reform and other regulatory issues (including failure to meet
statutory capital requirements), rising healthcare costs, adverse
outcomes in litigation and related matters, failure to comply with
financial and other covenants in our loan agreement, and
performance of our reinsurers. This review of important factors
should not be construed as exhaustive. Investors and others should
refer to Ceres' filings with the Securities and Exchange
Commission, including its annual report on Form 10-K for the year
ended December 31, 2004, and its quarterly reports on Form 10-Q and
other periodic filings, for a description of the foregoing and
other factors. Ceres undertakes no obligation to update
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events.
Ceres (NASDAQ:CERG)
Historical Stock Chart
From Apr 2024 to May 2024
Ceres (NASDAQ:CERG)
Historical Stock Chart
From May 2023 to May 2024